N@N

Law Office of Brodsky & Smith, LLC Announces Investigation of Talecris Biotherapeutics Holding Corp.

^{Published on 2010-06-10 14:45:22 - Market Wire}
 

BALA CYNWYD, Pa.--([ BUSINESS WIRE ])--Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Talecris Biotherapeutics Holding Corp. (aTalecrisa or the aCompanya) (Nasdaq:TLCR) relating to the proposed acquisition of Talecris by Grifols S.A. (aGrifolsa). Under the terms of the agreement, Talecris shareholders would receive $19.00 in cash and 0.641 newly-issued non-voting Grifolsa™ shares for each share of Talecris common stock they own.

The investigation concerns possible breaches of fiduciary duty and other violations of state law related to the Talecris boarda™s approval of the proposed transaction. The transaction appears to be unfair, in part, given that Talecris stock was trading at $24.12 a share as recently as February 2, 2010 and an analyst placed a $30 per share price target on Talecris.

If you own shares of Talecris and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at [ investorrelations@brodsky-smith.com ], or by calling toll free 877-LEGAL-90.